Kuehn Law Encourages Investors of Treace Medical Concepts, Inc. to Contact Law Firm

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by officers and directors of Treace Medical Concepts, Inc. (NASDAQ: TMCI) towards shareholders [1] Group 1: Allegations and Impact - A federal securities lawsuit claims that insiders at Treace Medical misrepresented or failed to disclose competition affecting the demand for its primary product, the Lapiplasty 3D Bunion Correction System [2] - As a result of the competition, Treace Medical's revenue declined, prompting the company to accelerate plans for an alternative product to osteotomy [2] - Positive statements regarding the company's business, operations, and prospects were allegedly materially misleading and lacked a reasonable basis [2]